454 WATSON (Gemfibrozil 600 mg)

Pill imprint 454 WATSON has been identified as Gemfibrozil 600 mg.

Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Gemfibrozil

Imprint:

454 WATSON

Strength:

600 mg

Color:

Orange

Size:

19.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fibric acid derivatives

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

National Drug Code (NDC):

00591-0454

Inactive Ingredients:

calcium stearate
silicon dioxide colloidal
croscarmellose sodium
FD&C Red No. 40 Aluminium Lake
FD&C Yellow No. 6 Aluminum Lake
hydroxypropyl cellulose
microcrystalline cellulose
polyethylene glycol
polysorbate 80
pregelatinized starch
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.